Metraipolis › archive › dc_d0dc021cfc93

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors — Europe PMC PMID:41744197

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41744197
DOI
10.1111/bjh.70402
License (as archived)
solo-consultazione
Archived
2026-11-05T11:02:24.357Z
SHA-256 of the archived text
38d5b7f7cf85e436a792aef0baf5c774391f7558510f98809ddbe58c72159245
Stable URL of this page
https://metraipolis.com/documento/dc_d0dc021cfc93

How to cite

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors — Europe PMC PMID:41744197 — Europe PMC (en), https://europepmc.org/article/MED/41744197 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d0dc021cfc93 (Metraipolis archive dc_d0dc021cfc93, sha256 38d5b7f7cf85e436a792aef0baf5c774391f7558510f98809ddbe58c72159245)
BibTeX
@misc{dcd0dc021cfc93,
  title = {Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors — Europe PMC PMID:41744197},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41744197},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d0dc021cfc93; sha256 38d5b7f7cf85e436a792aef0baf5c774391f7558510f98809ddbe58c72159245},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744197. Agents can read the archived copy with the MCP tool read_document.